fbpx
Mon. Jun 17th, 2024

Preclinical Alzheimer’s may be more prevalent than we think.

By Owner Dec 13, 2022

Amyloid Biomarkers Study indicated the prevalence of abnormal Amyloid was about 10% higher than previously estimated among people with normal cognition.

The study included 19,000 people in 85 cohorts. The study observed that, in persons without dementia, the cerebrospinal fluid-based amyloid abnormality prevalence estimate that used data-driven cutoffs was 10% higher than the positron emission tomography-based prevalence estimate that used cohort-provided cutoffs.

By Owner

Related Post

Social media & sharing icons powered by UltimatelySocial
error

Enjoy this blog? Please spread the word :)